English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/162119
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1

AutorGigante, Alba ; Gómez-SanJuan, Asier; Delang, Leen; Li, C.; Bueno, Oskía; Gamo, Ana María ; Priego, Eva María ; Camarasa Rius, María José ; Jochmans, D.; Leyssen, Pieter; Decroly, E.; Coutard, Bruno; Querat, Guilles; Neyts, Johan; Peréz-Pérez, María-Jesús
Palabras claveOximes
Chikungunya virus
Alphavirus
mRNA capping
Triazolopyrimidines
Fecha de publicación2017
EditorElsevier
CitaciónAntiviral Research 144: 216-222 (2017)
ResumenChikungunya virus (CHIKV) is a re-emerging alphavirus transmitted to humans by Aedes mosquitoes. Since 2005, CHIKV has been spreading worldwide resulting in epidemics in Africa, the Indian Ocean islands, Asia and more recently in the Americas. CHIKV is thus considered as a global health concern. There is no specific vaccine or drug available for the treatment of this incapacitating viral infection. We previously identified 3-aryl-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as selective inhibitors of CHIKV replication and proposed the viral capping enzyme nsP1 as a target. This work describes the synthesis of novel series of related compounds carrying at the aryl moiety a methylketone and related oximes combined with an ethyl or an ethyl-mimic at 5-position of the triazolopyrimidinone. These compounds have shown antiviral activity against different CHIKV isolates in the very low μM range based on both virus yield reduction and virus-induced cell-killing inhibition assays. Moreover, these antivirals inhibit the in vitro guanylylation of alphavirus nsP1, as determined by Western blot using an anti-cap antibody. Thus, the data obtained seem to indicate that the anti-CHIKV activity might be related to the inhibition of this crucial step in the viral RNA capping machinery.
Versión del editorhttp://dx.doi.org/10.1016/j.antiviral.2017.06.003
URIhttp://hdl.handle.net/10261/162119
Identificadoresdoi: 10.1016/j.antiviral.2017.06.003
issn: 0166-3542
e-issn: 1872-9096
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.